Cyber safety : a systems thinking and systems theory approach to managing cyber security risks by Salim, Hamid M

Get full text

Improving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review by Abel García Abejas, Adrià Serra Trullás, Maria Ana Sobral, Daniel Canelas, Fábio Leite Costa, Àngels Salvador Verges

“…At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.…”
Get full text

A dynamic model of the intestinal epithelium integrates multiple sources of preclinical data and enables clinical translation of drug‐induced toxicity by Louis Gall, Ferran Jardi, Lieve Lammens, Janet Piñero, Terezinha M. Souza, Daniela Rodrigues, Danyel G. J. Jennen, Theo M. deKok, Luke Coyle, Seung‐Wook Chung, Sofia Ferreira, Heeseung Jo, Kylie A. Beattie, Colette Kelly, Carrie A. Duckworth, D. Mark Pritchard, Carmen Pin

Get full text

Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration by Xiao-Dong Chen, Chan Li, Guo-Long Ding, Yan Suo, Yu-Sheng Zhu, Hui-Qin Lu

“…AIM: To evaluate the clinical efficacy and systemic safety profile of conbercept in clinical practice on vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PLGF) levels after intravitreal injections for the neovascular age-related macular degeneration (AMD). …”
Get full text

Safety Surveillance of Mass Praziquantel and Albendazole Co-Administration in School Children from Southern Ethiopia: An Active Cohort Event Monitoring by Tigist Dires Gebreyesus, Eyasu Makonnen, Tafesse Tadele, Habtamu Gashaw, Workagegnew Degefe, Heran Gerba, Birkneh Tilahun Tadesse, Parthasarathi Gurumurthy, Eleni Aklillu

“…Due to weak pharmacovigilance systems, safety monitoring during a mass drug administration (MDA) is lacking, especially in sub-Saharan Africa. …”
Get full text

VEGF Inhibition Associates With Decreased Risk of Mortality in Patients With Neovascular Age-related Macular Degeneration by Benjamin Sommer Thinggaard, MD, Katrine Frederiksen, MD, PhD, Yousif Subhi, MD, PhD, Sören Möller, PhD, Torben Lykke Sørensen, MD, DMSc, Ryo Kawasaki, MPH, PhD, Jakob Grauslund, MD, PhD, DMSc, Lonny Stokholm, PhD

“…Purpose: Controversy exists regarding the systemic safety of intravitreal VEGF inhibitors in the treatment of neovascular age-related macular degeneration (nAMD). …”
Get full text

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by... by Nelly R. Mugo, Nelly R. Mugo, Victor Mudhune, Renee Heffron, Renee Heffron, Katherine K. Thomas, Eleanor McLellan-Lemal, Betty Njoroge, Sue Peacock, Siobhán M. O’Connor, Beatrice Nyagol, Eunice Ouma, Renee Ridzon, Jeffrey Wiener, Nina Isoherranen, David W. Erikson, Louise A. Ouattara, Nazita Yousefieh, Terry A. Jacot, Richard E. Haaland, Susan A. Morrison, Harald S. Haugen, Andrea R. Thurman, Shannon A. Allen, Jared M. Baeten, Jared M. Baeten, Jared M. Baeten, Taraz Samandari, Taraz Samandari, Gustavo F. Doncel

“…In addition to assessing genital and systemic safety, we determined TFV concentrations in plasma and cervicovaginal fluid (CVF) and LNG levels in serum using tandem liquid chromatography-mass spectrometry. …”
Get full text

Global optimization of hybrid systems by Lee, Cha Kun

Get full text
Get full text

Development of optimized core design and analysis methods for high power density BWRs by Shirvan, Koroush

Get full text